4//SEC Filing
LEVITT DANIEL J 4
Accession 0001209191-18-030711
CIK 0001404644other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 7:45 PM ET
Size
12.6 KB
Accession
0001209191-18-030711
Insider Transaction Report
Form 4
LEVITT DANIEL J
Director
Transactions
- Sale
Common Stock
2018-05-14$12.67/sh−3,906$49,489→ 0 total - Exercise/Conversion
Common Stock
2018-05-14$10.56/sh+3,906$41,247→ 3,906 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-05-14−3,906→ 0 totalExercise: $10.56Exp: 2018-07-01→ Common Stock (3,906 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.65 to $12.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set in this footnote.
- [F2]All the shares subject to the 3,906 share option were fully vested.
Issuer
AQUINOX PHARMACEUTICALS, INC
CIK 0001404644
Entity typeother
Related Parties
1- filerCIK 0001278711
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 7:45 PM ET
- Size
- 12.6 KB